Heidi Hunter
Director/Board Member presso VICORE PHARMA HOLDING AB
Patrimonio netto: - $ in data 31/03/2024
Provenienza dei contatti di primo grado di Heidi Hunter
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 29 | |
25
| Public Company | Pharmaceuticals: Major | 25 |
| Public Company | Pharmaceuticals: Major | 20 | |
| Public Company | Pharmaceuticals: Major | 17 | |
| Public Company | Biotechnology | 16 | |
Boehringer Ingelheim International GmbH
 Boehringer Ingelheim International GmbH BiotechnologyHealth Technology Boehringer Ingelheim International GmbH manufactures pharmaceutical prodcuts. It offers human and animal health products. The company was founded by Albert Boehringer in 1885 and is headquartered in Ingelheim, Germany.
1
| Subsidiary | Biotechnology | 1 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Heidi Hunter tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal Director of Finance/CFO Investor Relations Contact Treasurer Corporate Officer/Principal Sales & Marketing | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Sales & Marketing Corporate Officer/Principal | |
| ASTRAZENECA PLC | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal | |
Axys Pharmaceuticals, Inc.
 Axys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Axys Pharmaceuticals, Inc. engages in the development of integrated drugs. The company is headquartered in South San Francisco, CA. | Pharmaceuticals: Major | President Corporate Officer/Principal | |
| CURIS, INC. | Biotechnology | Director/Board Member Corporate Officer/Principal | |
HBM Partners AG
 HBM Partners AG Investment ManagersFinance HBM Partners AG (HBM-P) was established in 2001 as an independent provider of investment advisory services with headquarters in Zug, Switzerland. HBM-P's field of expertise comprises global human medicine, biotechnology, medical technology and related sectors. The firm primarily advises HBM BioVentures AG and HBM BioCapital via their Cayman Islands-based, wholly-owned subsidiary, HBM Partners (Cayman) Ltd., which acts as the investment manager for the HBM funds. They rely on the services of an external consultant to analyze investment opportunities in the US. | Investment Managers | Private Equity Investor Private Equity Investor | |
| H. LUNDBECK A/S | Pharmaceuticals: Major | Chief Executive Officer Chief Tech/Sci/R&D Officer Director/Board Member Chief Executive Officer | |
Plexxikon, Inc.
 Plexxikon, Inc. Miscellaneous Commercial ServicesCommercial Services Plexxikon, Inc. provides clinical and medical drug discovery and development services. The company was founded by Joseph P. Schlessinger, Thomas Richard Kassberg, Sung-hou Kim and K. Peter Hirth in 2001 and is headquartered in Berkeley, CA. | Miscellaneous Commercial Services | Founder President | |
| CODEXIS, INC. | Chemicals: Specialty | Director/Board Member Director/Board Member Director/Board Member | |
| FIVE PRIME THERAPEUTICS, INC. | Biotechnology | Director of Finance/CFO Director/Board Member Chief Tech/Sci/R&D Officer | |
Elan Pharmaceuticals, LLC
 Elan Pharmaceuticals, LLC Pharmaceuticals: MajorHealth Technology Elan Pharmaceuticals LLC develops and manufactures pharmaceutical products. It specializes in treatment of neurological and autoimmune diseases. The firm's drugs are used in the treatment of for Alzheimer's, Parkinson's, and rheumatoid arthritis diseases. The company is headquartered in South San Francisco, CA. | Pharmaceuticals: Major | Human Resources Officer Corporate Officer/Principal | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Chairman Corporate Officer/Principal Director/Board Member Director/Board Member Director/Board Member | |
| ALMIRALL, S.A. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Chief Tech/Sci/R&D Officer | |
| NOVARTIS AG | Pharmaceuticals: Major | Sales & Marketing Director of Finance/CFO Corporate Officer/Principal | |
| GSK PLC | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| Stanford University | College/University | Masters Business Admin Undergraduate Degree Masters Business Admin | |
| GENMAB A/S | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO | |
Novo Holdings AS (Denmark)
 Novo Holdings AS (Denmark) MiscellaneousMiscellaneous Novo Holding A/S provides financial investments and manages the Novo Nordisk Foundation?s assets. It offers seed and venture capital to development stage companies and takes ownership positions in companies within life science and biotechnology. The company was founded on September 8, 1999 and is headquartered in Hellerup, Denmark. | Miscellaneous | Corporate Officer/Principal Director/Board Member | |
| ALK-ABELLÓ A/S | Biotechnology | Director/Board Member Director/Board Member | |
| Karolinska Institutet | College/University | Doctorate Degree Doctorate Degree Doctorate Degree Doctorate Degree | |
| University of California, Berkeley | College/University | Undergraduate Degree Doctorate Degree Undergraduate Degree | |
| Copenhagen Business School | College/University | Undergraduate Degree Corporate Officer/Principal Graduate Degree | |
| University of Uppsala | College/University | Corporate Officer/Principal Graduate Degree Graduate Degree | |
Vicore Pharma AB
 Vicore Pharma AB Pharmaceuticals: MajorHealth Technology Vicore Pharma AB researches and develops pharmaceutical products. The company is headquartered in Gothenburg, Sweden. | Pharmaceuticals: Major | Chief Executive Officer Chairman Corporate Officer/Principal | |
EMD Serono, Inc.
 EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Pharmaceuticals: Major | Corporate Officer/Principal General Counsel | |
| University of Lund | College/University | Graduate Degree Doctorate Degree Undergraduate Degree | |
| University of Copenhagen | College/University | Doctorate Degree Graduate Degree Doctorate Degree Corporate Officer/Principal Graduate Degree | |
| University of Utrecht | College/University | Doctorate Degree Doctorate Degree | |
| University of Zurich | College/University | Doctorate Degree Doctorate Degree | |
| Swiss Federal Institute of Technology | College/University | Graduate Degree Doctorate Degree | |
Merck Serono SA
 Merck Serono SA Medical SpecialtiesHealth Technology Merck Serono SA operates as a holding company in the pharmaceutical field. It engages in the research, development, manufacture, and distribution of therapeutic products for the treatment of human diseases. The company was founded on May 21, 1987 and is headquartered in Coinsins, Switzerland. | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal | |
European Federation of Pharmaceutical Industries & Assns
 European Federation of Pharmaceutical Industries & Assns Miscellaneous Commercial ServicesCommercial Services The European Federation of Pharmaceutical Industries & Assns is a trade association that promotes pharmaceutical discovery and development. The non-profit company is based in Brussels, Belgium. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member President Corporate Officer/Principal Director/Board Member | |
| University of Gothenburg | College/University | Doctorate Degree Doctorate Degree | |
| HANSA BIOPHARMA AB | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member Director/Board Member | |
| VOLUNTIS S.A. | Packaged Software | Director/Board Member Director/Board Member | |
| Harvard Medical School | College/University | Doctorate Degree Doctorate Degree | |
Neurelis, Inc.
 Neurelis, Inc. Pharmaceuticals: MajorHealth Technology Neurelis, Inc. operates as a specialty pharmaceutical company. It is organized to license, develop and commercialize product candidates for the treatment of central nervous system disorders with a focus on the acute treatment of epilepsy and anxiety episodes. The company was founded by Craig C. Chambliss and David F. Hale in 2007 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
UCB, Inc.
 UCB, Inc. Financial ConglomeratesFinance Part of UCB SA, UCB, Inc. provides financial services. The private company is based in Smyrna, GA. The CEO of the company is Duane Barnes. | Financial Conglomerates | Director/Board Member Corporate Officer/Principal Director/Board Member | |
| DIMENSION THERAPEUTICS INC | Biotechnology | Treasurer Director/Board Member | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin Masters Business Admin Masters Business Admin Masters Business Admin | |
| Harvard College | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| The University of Michigan Law School | College/University | Graduate Degree Graduate Degree | |
Anokion SA
 Anokion SA Medical/Nursing ServicesHealth Services Anokion SA provides technology for retraining white blood cells to induce therapeutic immune tolerance. The firm?s approach to antigen-specific immune tolerance can be translated to virtually any protein in numerous clinical indications. The company was founded by Jerffery Hubbell, Melody Swartz, Stephan Kontos, Oscar Buset, Kristen M. Lorentz and David A. Lowin and is headquartered in Ecublens, Switzerland. | Medical/Nursing Services | Director/Board Member Director/Board Member | |
Kanyos Bio, Inc.
 Kanyos Bio, Inc. Pharmaceuticals: MajorHealth Technology Kanyos Bio, Inc. engages in the provision of immune tolerance technology solutions. It develops antigen-specific for treatment of type-1 diabetes and celiac disease. The company was founded by Jeffrey Hubbell, Stephan Kontos, Oscar Buset, Kristen M. Lorentz, and David A. Lowin in 2015 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| VAXCYTE, INC. | Biotechnology | Director/Board Member Director/Board Member | |
| PHARVARIS N.V. | Pharmaceuticals: Major | Founder Director/Board Member Director/Board Member | |
IO Biotech ApS
 IO Biotech ApS BiotechnologyHealth Technology IO Biotech ApS operates as a clinical stage biotech company. It develops immunotherapy for cancer by targeting a mechanism used by tumour cells to evade immune responses. The company was founded by Mai-Britt Zocca, Mads Hald Andersen, Inge Marie Svane, Anders Ljungqvist and Per Thor Straten and is headquartered in Copenhagen, Denmark. | Biotechnology | Chairman Director/Board Member Director/Board Member Chief Executive Officer | |
INIM Pharma AB
 INIM Pharma AB Pharmaceuticals: MajorHealth Technology INIM Pharma AB operates as drug development company that focuses on the development of immunomodulatory drugs for interstitial lung diseases. It develops a new local treatment for severe rare lung diseases such as idiopathic pulmonary fibrosis. The company was founded by Carl-Johan Dalsgaard and is headquartered in Stockholm, Sweden. | Pharmaceuticals: Major | Chief Executive Officer Chairman Director/Board Member Director/Board Member | |
| ALIGOS THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
Bavarian Nordic GmbH
 Bavarian Nordic GmbH BiotechnologyHealth Technology Part of Bavarian Nordic A/S, Bavarian Nordic GmbH engages in research and development in biotechnology for cancer and infectious diseases. The private company is based in Martinsried, Germany. The German company was founded in 2014. Paul Chaplin has been the CEO of the company since 1999. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member Corporate Officer/Principal |
Statistiche
Distribuzione geografica
| Stati Uniti | 23 |
| Danimarca | 8 |
| Svezia | 8 |
| Svizzera | 6 |
| Regno Unito | 3 |
Settori
| Health Technology | 27 |
| Consumer Services | 16 |
| Commercial Services | 4 |
| Finance | 3 |
| Process Industries | 2 |
Posizioni
| Director/Board Member | 451 |
| Corporate Officer/Principal | 199 |
| Independent Dir/Board Member | 139 |
| Chairman | 89 |
| Chief Executive Officer | 62 |
Contatti più connessi
| Insiders | |
|---|---|
| Jack Nielsen | 38 |
| John Freund | 37 |
| Mark McDade | 35 |
| Jacob Uno Stanley Gunterberg | 33 |
| Sandrine Dufour | 29 |
| Thomas Fulton Wilson McKillop | 28 |
| Ulf Arne Wiinberg | 26 |
| Anders Gersel Pedersen | 24 |
| Michael Wolff Jensen | 23 |
| Jan Berger | 22 |
| Johannes G. C. P. Schikan | 22 |
| Harriet Edelman | 22 |
| Anne Eberhard | 21 |
| Carl-Johan Dalsgaard | 21 |
| Viviane Monges | 21 |
- Borsa valori
- Insiders
- Heidi Hunter
- Connessioni Società
